Brind.
  1. FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor.

Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.

1 report, 0 independent Updated Jun 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Medtronic plans to integrate with Abbott’s Libre sensors as both firms develop multi-analyte sensor technology.

Who's involved

What this event is mainly about
Medtronic plcAbbott Japan

How it developed

Newest first. Tap a step to see who reported it.
  1. Abbott Japan announces investments in new manufacturing and R&D facilities, coinciding with the availability of over-the-counter Continuous Glucose Monitoring (CGM).Sub-event
  2. Medtronic and Abbott are exploring integration of sensor technologies, with market entry dates estimated.

Keep exploring

Part of

FDA granted regulatory milestones to Medtronic, which is integrating with Abbott's Instinct sensor. All 2 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped
  • Unknown outlet